Management of Infection in Patients With Kidney Transplant

Kelly A Cawcutt, Andrea Zimmer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

With the pervasive nature of chronic kidney disease, kidney transplantation is likely to continue to increase in the coming years. There are many infectious risks related to kidney transplant, including reactivation of latent infections, surgical complications, infectious risks related to immunosuppression, and nosocomial and community-acquired infections. These are described classically via timeline with early infections (first month), middle (1 to 6 months), and late (after 6 months). Kidney transplant patients may suffer from infections secondary to a vast array of organisms, including bacteria, fungi, and viruses. Certain infections, particularly viral infections such as cytomegalovirus, Epstein-Barr virus, and BK virus, may portend acute and chronic implications of the infection and its subsequent impact on graft function. Critical care physicians and nephrologists caring for patients with a renal transplant must understand the broad array of possible infections, atypical presentations, and nuanced implications for appropriate evaluation and subsequent therapy, combined with the need for possible prophylaxis and/or suppression. Multidisciplinary teams, including transplant physicians and infectious diseases physicians, are encouraged strongly.

Original languageEnglish (US)
Title of host publicationCritical Care Nephrology
Subtitle of host publicationThird Edition
PublisherElsevier Inc.
Pages552-560.e1
ISBN (Electronic)9780323449427
ISBN (Print)9780323449427
DOIs
StatePublished - Jan 1 2019

Fingerprint

Transplants
Kidney
Infection
Physicians
BK Virus
Community-Acquired Infections
Virus Diseases
Critical Care
Cytomegalovirus
Human Herpesvirus 4
Coinfection
Chronic Renal Insufficiency
Kidney Transplantation
Immunosuppression
Communicable Diseases
Fungi
Viruses
Bacteria
Therapeutics

Keywords

  • Bacterial infections
  • Fungal infections
  • Immunosuppression
  • Intensive care unit
  • Kidney transplant
  • Viral infections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cawcutt, K. A., & Zimmer, A. (2019). Management of Infection in Patients With Kidney Transplant. In Critical Care Nephrology: Third Edition (pp. 552-560.e1). Elsevier Inc.. https://doi.org/10.1016/B978-0-323-44942-7.00095-9

Management of Infection in Patients With Kidney Transplant. / Cawcutt, Kelly A; Zimmer, Andrea.

Critical Care Nephrology: Third Edition. Elsevier Inc., 2019. p. 552-560.e1.

Research output: Chapter in Book/Report/Conference proceedingChapter

Cawcutt, KA & Zimmer, A 2019, Management of Infection in Patients With Kidney Transplant. in Critical Care Nephrology: Third Edition. Elsevier Inc., pp. 552-560.e1. https://doi.org/10.1016/B978-0-323-44942-7.00095-9
Cawcutt KA, Zimmer A. Management of Infection in Patients With Kidney Transplant. In Critical Care Nephrology: Third Edition. Elsevier Inc. 2019. p. 552-560.e1 https://doi.org/10.1016/B978-0-323-44942-7.00095-9
Cawcutt, Kelly A ; Zimmer, Andrea. / Management of Infection in Patients With Kidney Transplant. Critical Care Nephrology: Third Edition. Elsevier Inc., 2019. pp. 552-560.e1
@inbook{4597d30ed2864c7d914d4a187340cb02,
title = "Management of Infection in Patients With Kidney Transplant",
abstract = "With the pervasive nature of chronic kidney disease, kidney transplantation is likely to continue to increase in the coming years. There are many infectious risks related to kidney transplant, including reactivation of latent infections, surgical complications, infectious risks related to immunosuppression, and nosocomial and community-acquired infections. These are described classically via timeline with early infections (first month), middle (1 to 6 months), and late (after 6 months). Kidney transplant patients may suffer from infections secondary to a vast array of organisms, including bacteria, fungi, and viruses. Certain infections, particularly viral infections such as cytomegalovirus, Epstein-Barr virus, and BK virus, may portend acute and chronic implications of the infection and its subsequent impact on graft function. Critical care physicians and nephrologists caring for patients with a renal transplant must understand the broad array of possible infections, atypical presentations, and nuanced implications for appropriate evaluation and subsequent therapy, combined with the need for possible prophylaxis and/or suppression. Multidisciplinary teams, including transplant physicians and infectious diseases physicians, are encouraged strongly.",
keywords = "Bacterial infections, Fungal infections, Immunosuppression, Intensive care unit, Kidney transplant, Viral infections",
author = "Cawcutt, {Kelly A} and Andrea Zimmer",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/B978-0-323-44942-7.00095-9",
language = "English (US)",
isbn = "9780323449427",
pages = "552--560.e1",
booktitle = "Critical Care Nephrology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Management of Infection in Patients With Kidney Transplant

AU - Cawcutt, Kelly A

AU - Zimmer, Andrea

PY - 2019/1/1

Y1 - 2019/1/1

N2 - With the pervasive nature of chronic kidney disease, kidney transplantation is likely to continue to increase in the coming years. There are many infectious risks related to kidney transplant, including reactivation of latent infections, surgical complications, infectious risks related to immunosuppression, and nosocomial and community-acquired infections. These are described classically via timeline with early infections (first month), middle (1 to 6 months), and late (after 6 months). Kidney transplant patients may suffer from infections secondary to a vast array of organisms, including bacteria, fungi, and viruses. Certain infections, particularly viral infections such as cytomegalovirus, Epstein-Barr virus, and BK virus, may portend acute and chronic implications of the infection and its subsequent impact on graft function. Critical care physicians and nephrologists caring for patients with a renal transplant must understand the broad array of possible infections, atypical presentations, and nuanced implications for appropriate evaluation and subsequent therapy, combined with the need for possible prophylaxis and/or suppression. Multidisciplinary teams, including transplant physicians and infectious diseases physicians, are encouraged strongly.

AB - With the pervasive nature of chronic kidney disease, kidney transplantation is likely to continue to increase in the coming years. There are many infectious risks related to kidney transplant, including reactivation of latent infections, surgical complications, infectious risks related to immunosuppression, and nosocomial and community-acquired infections. These are described classically via timeline with early infections (first month), middle (1 to 6 months), and late (after 6 months). Kidney transplant patients may suffer from infections secondary to a vast array of organisms, including bacteria, fungi, and viruses. Certain infections, particularly viral infections such as cytomegalovirus, Epstein-Barr virus, and BK virus, may portend acute and chronic implications of the infection and its subsequent impact on graft function. Critical care physicians and nephrologists caring for patients with a renal transplant must understand the broad array of possible infections, atypical presentations, and nuanced implications for appropriate evaluation and subsequent therapy, combined with the need for possible prophylaxis and/or suppression. Multidisciplinary teams, including transplant physicians and infectious diseases physicians, are encouraged strongly.

KW - Bacterial infections

KW - Fungal infections

KW - Immunosuppression

KW - Intensive care unit

KW - Kidney transplant

KW - Viral infections

UR - http://www.scopus.com/inward/record.url?scp=85055370406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055370406&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-44942-7.00095-9

DO - 10.1016/B978-0-323-44942-7.00095-9

M3 - Chapter

AN - SCOPUS:85055370406

SN - 9780323449427

SP - 552-560.e1

BT - Critical Care Nephrology

PB - Elsevier Inc.

ER -